Table 1 from Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecological cancers | Semantic Scholar
CA 19.9 - Pancreatic Cancer Marker – Beacon Health Screening Centre
Old Dog, New Tricks: Use of CA 19-9 for Early Diagnosis of Pancreatic Cancer - Gastroenterology
Tumor markers in pancreatic cancer: a European Group on Tumor Markers (EGTM) status report. | Semantic Scholar
PDF] Assessing Prognosis in Metastatic Pancreatic Cancer by the Serum Tumor Marker CA 19-9: Pretreatment Levels or Kinetics during Chemotherapy? | Semantic Scholar
CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trial - The Lancet Oncology
Tumor markers- Dr. Enja Amarnath Reddy | PPT
Diseases | Free Full-Text | Diagnostic and Prognostic Value of CEA and CA19- 9 in Colorectal Cancer
Tumour markers | PPT
CA-19-9 - Diagnostic Kit
Serum levels of CEA and CA19.9 tumor markers in individual patients | Download Table
Evaluating the efficacy of tumor markers CA 19-9 and CEA to predict operability and survival in pancreatic malignancies
Tumormarker - Medizinisches Labor Prof. Schenk / Dr. Ansorge und Kollegen
Clinical Value of Serum CEA, CA 19-9, CA 242 and AFP in Diagnosis of Gastrointestinal Tract Cancers